The Effect of A-PRF+ Versus Open Flap Debridement in the Treatment of Patients With Stage III Per… (NCT03924336) | Clinical Trial Compass
CompletedNot Applicable
The Effect of A-PRF+ Versus Open Flap Debridement in the Treatment of Patients With Stage III Periodontitis
Egypt22 participantsStarted 2019-09-30
Plain-language summary
To assess the effectiveness of advanced PRF+ as compared to open flap debridement in treatment of periodontal intraosseous defects in stage III periodontitis patients.
Who can participate
Age range18 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Stage III periodontitis patient having at least one tooth with 2-wall, 3-wall, or combined 2- to 3-wall intraosseous defect ≥ 3 mm in depth (assessed by bone sounding, radiographic examination) with clinical attachment level (CAL) ≥ 5mm and pocket depth (PD) ≥ 6 mm.
* Defect not extending to a root furcation area
* Non-smokers.
* No history of intake of medications affecting the periodontium in the previous 6 months.
* Able to sign an informed consent form.
* Patients age between 18 and 60 years old.
* Patients who are cooperative, motivated, and hygiene conscious.
* Systemically free according to Cornell Medical Index (Broadbent, 1951).
Exclusion Criteria:
* Pregnancy or breast feeding
* The presence of an orthodontic appliance
* Teeth mobility greater than grade I
What they're measuring
1
Clinical Attachment Level (CAL) gain
Timeframe: Change from Baseline Clinical Attachment Level (CAL) at 9 months